<DOC>
	<DOCNO>NCT01387308</DOCNO>
	<brief_summary>Study healthy male assess bioavailability 4 different fostamatinib tablet .</brief_summary>
	<brief_title>Study Healthy Males Assess Bioavailability 4 Different Fostamatinib Tablets</brief_title>
	<detailed_description />
	<criteria>Provision sign date informed consent prior study specific procedures Volunteers male age 18 55 year weight least 50 kg body mass index ( BMI ) 18 30 kg/m2 inclusive Volunteers agree participate optional genetic research must provide separate , sign , write date informed consent genetic research . The volunteer exclude aspect study describe Clinical Study Protocol long consent History clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result subject 's ability participate study History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration investigational product Subjects smoke 5 cigarette equivalent tobacco per day Any clinically significant abnormality clinical chemistry , haematology urinalysis result judge investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Healthy male volunteer</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>fostamatinib</keyword>
	<keyword>Scientific Terminology : Bioavailability , R406 plasma AUC C_maxR406 plasma AUC0-t , t1/2Î»z t_max</keyword>
	<keyword>Laymen Terminology : Amount R406 blood</keyword>
</DOC>